2.25
price up icon2.27%   0.05
after-market アフターアワーズ: 2.26 0.010 +0.44%
loading
前日終値:
$2.20
開ける:
$2.2
24時間の取引高:
1.07M
Relative Volume:
0.53
時価総額:
$474.18M
収益:
$314.00K
当期純損益:
$-40.23M
株価収益率:
-8.0357
EPS:
-0.28
ネットキャッシュフロー:
$-84.71M
1週間 パフォーマンス:
-3.43%
1か月 パフォーマンス:
+9.22%
6か月 パフォーマンス:
+80.00%
1年 パフォーマンス:
+73.08%
1日の値動き範囲:
Value
$2.1747
$2.25
1週間の範囲:
Value
$2.00
$2.51
52週間の値動き範囲:
Value
$1.03
$2.64

Atai Life Sciences N V Stock (ATAI) Company Profile

Name
名前
Atai Life Sciences N V
Name
セクター
Healthcare (1170)
Name
電話
49 89 2153 9035
Name
住所
WALLSTRASSE 16, BERLIN
Name
職員
54
Name
Twitter
Name
次回の収益日
2024-12-11
Name
最新のSEC提出書
Name
ATAI's Discussions on Twitter

ATAI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ATAI
Atai Life Sciences N V
2.25 474.18M 314.00K -40.23M -84.71M -0.28
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.40 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
318.25 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.04 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
254.49 28.51B 3.81B -644.79M -669.77M -6.24

Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-18 繰り返されました H.C. Wainwright Buy
2024-04-03 アップグレード Maxim Group Hold → Buy
2022-11-01 開始されました Loop Capital Buy
2021-11-30 開始されました Maxim Group Buy
2021-11-11 開始されました ROTH Capital Buy
2021-10-18 開始されました H.C. Wainwright Buy
2021-09-01 開始されました Jefferies Buy
2021-07-13 開始されました Berenberg Buy
2021-07-13 開始されました Canaccord Genuity Buy
2021-07-13 開始されました Cantor Fitzgerald Buy
2021-07-13 開始されました Citigroup Buy
2021-07-13 開始されました Cowen Outperform
2021-07-13 開始されました Credit Suisse Outperform
2021-07-13 開始されました RBC Capital Mkts Sector Perform
2021-07-08 開始されました Aegis Capital Buy
すべてを表示

Atai Life Sciences N V (ATAI) 最新ニュース

pulisher
Jun 18, 2025

ATAI Sees Potential Boost from U.S. Policy Shift on Psychedelics - GuruFocus

Jun 18, 2025
pulisher
Jun 15, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders - GlobeNewswire

Jun 15, 2025
pulisher
Jun 15, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders - GlobeNewswire Inc.

Jun 15, 2025
pulisher
Jun 13, 2025

ATAI’s Stock Dilemma: ATAI Life Sciences N.V’s Market Performance and Outlook - investchronicle.com

Jun 13, 2025
pulisher
Jun 13, 2025

SELLAS Life Sciences Group Inc (SLS) Stock: A Year of Highs and Lows - investchronicle.com

Jun 13, 2025
pulisher
Jun 12, 2025

Atai Life Sciences (ATAI) Garnered a Buy Rating and $12 Target | ATAI Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 09, 2025

Are You Looking for a Top Momentum Pick? Why atai Life Sciences N.V. (ATAI) is a Great Choice - Yahoo Finance

Jun 09, 2025
pulisher
Jun 09, 2025

Is atai Life Sciences (ATAI) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jun 09, 2025
pulisher
Jun 07, 2025

Lucid Capital Markets initiates coverage on atai Life Sciences stock By Investing.com - Investing.com Nigeria

Jun 07, 2025
pulisher
Jun 06, 2025

ATAI Gains Buy Rating and Price Target from Lucid Capital | ATAI Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Lucid Capital Markets initiates coverage on atai Life Sciences stock - Investing.com

Jun 06, 2025
pulisher
Jun 05, 2025

ATAI and Beckley Psytech Set to Merge in Strategic All-Share Dea - GuruFocus

Jun 05, 2025
pulisher
Jun 04, 2025

Regeneron makes obesity push; Atai, Alto ink brain drug deals - Yahoo Finance

Jun 04, 2025
pulisher
Jun 03, 2025

Atai Life Sciences Merges With Beckley Psytech In Major Shakeup - Finimize

Jun 03, 2025
pulisher
Jun 03, 2025

ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Atai Life Sciences N.V. is Fair to Shareholders - Business Wire

Jun 03, 2025
pulisher
Jun 03, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BPMC, STRM, ATAI, STR on Behalf of Shareholders - Morningstar

Jun 03, 2025
pulisher
Jun 03, 2025

H.C. Wainwright maintains buy rating on atai Life Sciences stock By Investing.com - Investing.com India

Jun 03, 2025
pulisher
Jun 03, 2025

H.C. Wainwright maintains buy rating on atai Life Sciences stock - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Atai in $370M merger deal with psychedelic drug specialist Beckley - BioWorld MedTech

Jun 03, 2025
pulisher
Jun 02, 2025

atai Life Sciences (ATAI) Merges with Beckley Psytech for Psyche - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

atai Life Sciences and Beckley Psytech merging - Seeking Alpha

Jun 02, 2025
pulisher
Jun 02, 2025

Atai Life Sciences, Beckley Psytech to Merge in All-Stock Transaction - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Transcript : Atai Life Sciences N.V., Beckley Psytech LimitedM&A Call - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Thiel-Backed Psychedelic Drugmaker Atai to Combine With Beckley - Bloomberg

Jun 02, 2025
pulisher
Jun 02, 2025

ATAI and Beckley Psytech Plan Merger in Strategic All-Share Deal | ATAI Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies - Yahoo Finance

Jun 02, 2025
pulisher
Jun 02, 2025

ATAI Life Sciences stock soars on Beckley Psytech merger deal By Investing.com - Investing.com UK

Jun 02, 2025
pulisher
May 30, 2025

Beckley Psytech & atai Life Sciences to combine expertise in pivotal merger - Mugglehead Magazine

May 30, 2025
pulisher
May 29, 2025

atai Life Sciences to Participate in Upcoming Investor Conferences - Yahoo

May 29, 2025
pulisher
May 27, 2025

2 ‘Strong Buy’ Psychedelic Stocks To Scoop Up ASAP - Barchart.com

May 27, 2025
pulisher
May 24, 2025

Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors - Benzinga

May 24, 2025
pulisher
May 23, 2025

atai Life Sciences N.V. (ATAI) Is Up 18.71% in One Week: What You Should Know - Nasdaq

May 23, 2025
pulisher
May 22, 2025

atai Life Sciences N.V. (ATAI) Just Flashed Golden Cross Signal: Do You Buy? - sharewise

May 22, 2025
pulisher
May 22, 2025

Is atai Life Sciences (ATAI) Outperforming Other Medical Stocks This Year? - Yahoo Finance

May 22, 2025
pulisher
May 21, 2025

atai Life Sciences holds annual general meeting - Investing.com Australia

May 21, 2025
pulisher
May 21, 2025

atai Life Sciences holds annual general meeting By Investing.com - Investing.com India

May 21, 2025
pulisher
May 21, 2025

ATAI Life Sciences Approves Key Governance Changes - TipRanks

May 21, 2025
pulisher
May 21, 2025

Phase 2a data for BPL-003 ‘encouraging’ for Atai Life Sciences, says Jefferies - Yahoo Finance

May 21, 2025
pulisher
May 21, 2025

ATAI Life Sciences Sees Significant Rise in Borrow Rate | ATAI S - GuruFocus

May 21, 2025

Atai Life Sciences N V (ATAI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Atai Life Sciences N V (ATAI) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Kirpekar Sahil
Chief Business Officer
Mar 21 '25
Sale
1.35
48,563
65,560
115,636
Craig Kevin James
Chief Medical Officer
Mar 21 '25
Sale
1.35
11,563
15,610
8,437
Rao Srinivas
See Remarks
Mar 21 '25
Sale
1.35
75,418
101,814
212,942
Johnson Anne Nagengast
Chief Financial Officer
Mar 21 '25
Sale
1.35
33,545
45,286
140,045
Short Glenn Frank
Chief Scientific Officer
Mar 21 '25
Sale
1.35
13,161
17,767
42,333
$20.73
price up icon 1.02%
$35.27
price down icon 1.78%
$21.32
price up icon 0.24%
$101.74
price down icon 2.97%
$106.14
price up icon 1.28%
biotechnology ONC
$254.49
price down icon 4.73%
大文字化:     |  ボリューム (24 時間):